Impact Partnership Wealth’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-263
Closed -$3.51K 251
2024
Q2
$3.51K Hold
263
﹤0.01% 217
2024
Q1
$12.2K Hold
263
﹤0.01% 429
2023
Q4
$17.7K Hold
263
0.01% 426
2023
Q3
$19K Hold
263
0.01% 499
2023
Q2
$19.5K Buy
+263
New +$15.6K 0.01% 341

Other funds holding DNA

Impact Partnership Wealth's DNA Position: Q3 2024 in Review

Impact Partnership Wealth sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 263 shares — an estimated $3.51K sold.

Impact Partnership Wealth first reported a position in DNA in Q2 2023 and held it in 5 quarters. The position peaked at $19.5K in Q2 2023. 159 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

  • Impact Partnership Wealth reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
  • Impact Partnership Wealth sold 263 Ginkgo Bioworks shares in Q3 2024, an estimated $3.51K.
  • Impact Partnership Wealth first reported a position in Ginkgo Bioworks in Q2 2023 and held it in 5 quarters.
  • Impact Partnership Wealth's Ginkgo Bioworks position peaked at $19.5K in Q2 2023.
  • 159 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on Impact Partnership Wealth's 13F filing for Q3 2024, filed 22 Oct 2024.